


This market contraction reflects shifting dynamics such as the saturation of ethanol-based disinfectants following the COVID-19 pandemic and increased regulatory scrutiny on alcohol-based pharmaceutical formulations.
Historically, demand surged during the 2020–2022 period due to heightened needs for hand sanitizers, antiseptics, and disinfectants.
However, with the normalization of demand and increased diversification into non-alcohol-based disinfectant alternatives, the market is facing a period of adjustment. Despite the decline, consistent use in pharmaceutical production ensures a stable baseline demand.
Projections:
Market Value in 2024: USD 1204.05million
Projected Value by 2031: USD 1092.99million
CAGR
By Application
By Region
Personal Care & Cosmetic
The United States and Canada dominate this region due to their advanced pharmaceutical industries and strong domestic ethanol production. The U.S. alone accounted for over 30% of the global pharmaceutical ethanol consumption in 2023. FDA regulations also contribute to the standardization and quality control of the market.
Countries like Germany, the UK, and France lead the European market. Strict EU regulations and a growing preference for bioethanol variants are reshaping the supply chain. Pharmaceutical firms are also increasingly outsourcing production to Eastern Europe to cut costs.
Follow
LinkedIn: https://www.linkedin.com/company/24 chemicalresearchold/posts/ Facebook: https://www.facebook.com/24chemicalr esearch/ Twitter: https://x.com/24Chemical